iSpecimen Invests $200M in Solana Treasury Amid 20x Demand
In early August, biotech firm iSpecimen announced plans to allocate $200 million to its Solana treasury. The move is part of the company’s digital asset diversification strategy and reflects a broader trend: public companies’ demand for SOL assets surged 20× in 2025, rising from 173,000 to 3.44 million SOL (now valued at $647 million). Key treasury players include Upexi, DeFi Development Corporation, SOL Strategies and Neptune Digital Assets. Firms benefit from potential price appreciation, staking yields exceeding 7%, and DeFi strategies. Despite Bitcoin and Ethereum remaining dominant among corporate treasuries, interest in Solana treasury solutions is growing. SOL’s price cooled after mid-July profit-taking but showed bullish signals with long positions rebounding to 72%. Traders eye a break above $180 to confirm a recovery beyond the recent ~$200 peak.
Bullish
The announcement of a $200 million Solana treasury by iSpecimen signals strong institutional interest and underscores a broader shift toward alternative crypto holdings beyond Bitcoin and Ethereum. Similar to how MicroStrategy’s Bitcoin purchases in 2020–2021 fueled BTC’s rally, large-scale SOL acquisitions can drive price appreciation by tightening supply and boosting market confidence. In the short term, this news may trigger renewed buying pressure as traders position for a breakout above key resistance levels (notably $180 and the prior ~$200 peak). The rebound in long positions to 72% suggests growing bullish sentiment. Over the long term, steady corporate treasury demand could deepen liquidity, support network security through staking yields exceeding 7%, and validate Solana’s role in institutional portfolios. The combination of capital inflows and DeFi utility positions SOL for sustained upside, making this development a bullish catalyst.